Matrix Laboratories (Delisted) share news and announcements

BSE: 524794

Last traded ₹209.35 on 13 Aug 2009

Delisted on 21 Aug 2009.

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Matrix Laboratories quarterly results

Jul29Wed

The board met on 29 Jul 2009 to consider “Unaudited Financial Results for the Qtr ended June 30, 2009”

Notice filed 21 Jul 2009

Matrix Laboratories annual reports, presentations and earnings calls

The company's own documents, latest first.Matrix Laboratories financials, year by year

Annual reports16

11 earlier reports

Matrix Laboratories share news and announcements

107 announcements, routine notices left out, newest first. Page 1 of 3.

  1. Aug 2009

    • 17 Aug · Disclosure

      Company has received disclosures under regulation 13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992 from Employees of the Company. In this connection, the company has submitted to the Exchange the disclosure under regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 7 Aug · Business

      Vide its letter dated August 07, 2009, regarding a press release dated August 06, 2009, titled "President Clinton and Mylan Chairman and CEO Robert J. Coury announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  2. Jul 2009

    • 31 Jul · Suspension and Delisting of trading in equity shares

      Members of the Exchange are hereby informed that the trading in the equity shares of Matrix Laboratories Limited shall be suspended w.e.f. August 14, 2009 (i.e. w.e.f. closing hours of trading on August 13, 2009) on account of voluntary delisting pursuant to the SEBI (Delisting of Securities) Guidelines, 2003. The admission to dealings in securities of the said company shall be withdrawn (delisted) w.e.f. August 21, 2009.

    • 31 Jul · Delisting of shares

      Matrix Laboratories Limited has, with reference to the Delisting of the equity shares of the Company from the Exchange, submitted to the Exchange the details of the name, address and contact numbers of the Contact Person at RTA and at the Company for solving Investor queries post Delisting. The details of the same are as follows: 1) Company:- Name: V. Sheela; Designation: Company Secretary & General Manager (Legal); Address: 1-1-151/1, IV Floor, Sairam Towers, Alexander Road, Secunderabad - 500003; Phone: 91 40 27700363, 30496666; Fax: 91 40 27700343; Email: [email protected] 2) Registrar to the Delisting Offer:- Name: Nilesh Chalke; Address: Link Intime India Private Limited; Address: C-13, Pannalal Silk Mills Compound, L.B.S. Marg, Bhandup (W), Mumbai - 400078; Phone: 91 22 2596 0320; Fax: 91 22 2596 0329; Email: [email protected] 3) Registrar of the Company:- Name: E.S.K. Prasad; Address: Venture Capital & Corporate Investments Private Limited (Unit Matrix Laboratories Limited) 12-10-167, Bharatnagar, Hyderabad - 500018; Phone: 91 40 23818475 / 23818476; Fax: 91 40 23868024; Email: [email protected].

    • 29 Jul · Results

      Standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 40555 lacs for quarter ending on 30-JUN-2009 against Rs. 32555 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 1656 lacs for the quarter ending on 30-JUN-2009 against Rs. 3237 lacs for the quarter ending on 30-JUN-2008.

    • 21 Jul · Board meeting

      Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”

    • 2 Jul · Meeting

      Proceedings of the Extraordinary General Meeting of the Company held on May 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  3. Jun 2009

    • 26 Jun · Results

      Standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 147903 lacs for year ending on 31-MAR-2009 against Rs. 97876.4 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 18895 lacs for the year ending on 31-MAR-2009 against Rs. (29835.7) lacs for the year ending on 31-MAR-2008.

    • 26 Jun · Results

      Consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 227385 lacs for year ending on 31-MAR-2009 against Rs. 176158.9 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 2999 lacs for the year ending on 31-MAR-2009 against Rs. (45692.7) lacs for the year ending on 31-MAR-2008.

    • 24 Jun · Allotment of Equity Shares

      With reference to Allotment of Equity Shares under ESOP Schemes that "The Board of Directors of the Company by circulation, have alloted 17,25,170 Equity Shares of Rs 2/- each to Matrix ESOP Trust under ESOP Schemes. Consequent to the above allotment , the paid up share capital of the Company has increased to Rs 31,26,77,622/-".

    • 15 Jun · Board meeting

      Inter-alia to consider and approve the Audited Financial Results of the Company for the Fourth Quarter and Year ended March 31, 2009.

    • 1 Jun · Business

      Press release dated June 01, 2009, titled "Matrix and Aspen complete divestment of Joint Ventures" A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 1 Jun · Public Announcement

      Public Announcement in continuation and should be read in conjunction with the original public announcement dated May 05, 2009 ("Original Public Announcement"), the bid letter dated May 06, 2009 ("Bid Letter") and the corrigendum to the Original Public Announcement and Bid Letter dated May 22, 2009 ("Corrigendum"), in connection with the proposed acquisition and delisting of the fully paid-up equity shares ("Shares") of Matrix Laboratories Limited (the "Company") by MP Laboratories (Mauritius) Ltd (the "Acquirer") under the Delisting Guidelines (the "Delisting Offer"). A copy of the public announcement shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  4. May 2009

    • 30 May · Meeting

      Members of the Company at the Extraordinary General Meeting held on May 30, 2009 have approved the following special resolutions with requisite majority : (1) Approval of the amendment to the Employee Stock Option Plan 2004, (2) Approval of the amendment to the Employee Stock Option Plan -1 2006, (3) Approval of the amendment to the Employee Stock Option Plan - 2 2006, and (4) Allotment of upto 18,39,345 Equity Shares of the Face Value of Rs. 2/- each to the Matrix ESOP Trust.

    • 28 May · Meeting

      Proceedings of the Extraordinary General Meeting of the Company held on April 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 26 May · Corrigendum

      Corrigendum to the Public Announcement in connection with the Proposed acquisition and delisting of the fully paid-up equity shares ("Shares") of Matrix Laboratories Limited (the "Company") by MP Laboratories (Mauritius) Ltd (the "Acquirer") under the Delisting Guidelines (the "Delisting Offer"). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 23 May · Business

      Press release dated May 22, 2009, titled "Matrix assigns its right and obligation to purchase 1% equity shares of Astrix Laboratories Limited to Mylan Luxembourg 2 S.a.r.l." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 7 May · Updates

      Vide its letter dated May 07, 2009 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2009 under US GAAP reporting, which inter alia, included the following unaudited details of Matrix: Segment profitability (on a US GAAP basis) of $22,739,000 for the three months ended 31st March, 2009 (which includes the effect of $23,332,000 of inter-company revenues). Please note that financial results of Matrix for the quarter ended / year ended 31st March, 2009 are yet to be reported under Indian GAAP and the above information is as reported by Mylan, which is being forwarded to you by Matrix for your information. Please also note that Indian GAAP and U.S. GAAP differ in certain significant respects, and the US GAAP figures reported above may not be indicative of the results under Indian GAAP".

    • 5 May · Public Announcement - Delisting

      Public announcement ("Public Announcement") being issued by MP Laboratories (Mauritius) Ltd (hereinafter referred to as the "Acquirer") to the public shareholders of Matrix Laboratories Limited ("Company") in respect of the proposed acquisition of the Offer Shares (as hereinafter defined) and consequent delisting of the fully paid-up equity shares of the Company with a face value of Rs.2 each ("Equity Shares") in accordance with the Securities and Exchange Board of India (Delisting of Securities) Guidelines, 2003 ("Guidelines") (hereinafter referred to as the "Delisting Offer"). The Acquirer and Mr. Prasad Nimmagadda ("N. Prasad") are the promoters of the Company and collectively hold 76.13% of the fully paid-up equity share capital of the Company ("Share Capital") as on the date of this Public Announcement, with the Acquirer holding 71.16% and N. Prasad holding 4.97% of the Share Capital respectively. The Delisting Offer: The Acquirer is making this Public Announcement to the public holders of Equity Shares ("Public Shareholders"), subject to the conditions mentioned in paragraph 11 of this Public Announcement, to acquire in accordance with the Guidelines and on the terms and subject to the conditions set out in the Public Announcement up to 3,87,50,534 Equity Shares, representing approximately 24.77% of the fully diluted share capital of the Company (the "Offer Shares") and delist the Equity Shares from the BSE and the NSE. The Bid Opening Date is May 25, 2009 & the Bid Closing Date is May 29, 2009. A copy of the Public Announcement - Delisting shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 5 May · Meeting

      Notice of the Extraordinary General Meeting of the members of the Company to be held on May 30, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 4 May · Disclosure

      Board of Directors of the Company vide their Resolutions passed through circulation on May 03, 2009 approved the following proposals: (1) Amendments to the ESOP 2004 Plan, ESOP 2006-1 Plan and ESOP 2006-2 Plan (collectively 'Esop Plans') subject to the approval of the Shareholders. (2) Issue and allotment of upto 1,839,345 equity shares of the Company to a trust to be formed and settled by the Company with the object, inter alia, of the benefit of the present, former and future employees and directors of the Company and of subsidiaries of the Company (hereinafter 'ESOP Trust') to give effect to the abovementioned modifications to the Esop plans. (3) To convene an Extraordinary General Meeting of the Company on May 30, 2009 to approve the amendments to the ESOP Plans and the issuance of up to 1,839,345 equity shares of the Company to the ESOP Trust.

    • 4 May · Updates

      Vide its letter dated April 30, 2009 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported in its earnings release today (30th April, 2009 in the U.S.), the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2009 under US GAAP reporting, which inter alia included the following unaudited details of Matrix: Net revenues (third party) for the three months ended 31st March, 2009 (on a US GAAP basis) - U.S. $ 102.6 million. Please note that financial results of Matrix for the quarter ended / year ended 31st March, 2009 are yet to be reported under Indian GAAP and the above information is as reported by Mylan, which is being forwarded to you by Matrix for your information. Please also note that Indian GAAP and U.S. GAAP differ in certain significant respects, and the US GAAP figure reported above may not be indicative of the results under Indian GAAP".

  5. Apr 2009

    • 30 Apr · Meeting

      Members of the Company at the Extraordinary General Meeting held on April 30, 2009 have approved the following business: 1) Voluntary delisting of the equity shares of the Company from the Bombay Stock Exchange Limited and National Stock Exchange of India Limited pursuant to the Securities and Exchange Board of India ( Delisting of Securities ) Guidelines, 2003. 2) Appointment of Mr. S. Srinivasan as Chief Executive Officer & Managing Director of the Company.

    • 28 Apr · Results

      Company will publish audited financial results for the financial year ending March 31, 2009 within three months i.e. by June 30, 2009 and hence the Company would not be publishing the unaudited financial results for the last quarter ended March 31, 2009.

    • 21 Apr · Business

      Press release dated April 20, 2009, titled "Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 9 Apr · Meeting

      Notice of the Extraordinary General Meeting of Equity Shareholders of the Company to be held on April 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  6. Mar 2009

    • 31 Mar · Business

      Press release dated March 30, 2009, titled "Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 30 Mar · Meeting

      Pursuant to a resolution passed by the board of directors of the Company dated March 27, 2009, the board of directors have: (1) taken on record the proposal received from MP Laboratories (Mauritius) Ltd dated March 26, 2009, to initiate a voluntary delisting offer to the public shareholders of the Company to delist the shares of the Company from the Bombay Stock Exchange Limited and National Stock Exchange of India Limited; (2) decided that the above matter will be placed before the shareholders for consideration and consent at the extra-ordinary general meeting which has been convened on April 30, 2009 and (3) approved the draft notice convening the extra-ordinary general meeting which has been convened on April 30, 2009 (along with the explanatory statement).

    • 27 Mar · Delisting of Securities

      "The Board of Directors of Matrix Laboratories Limited ("Company") has received a letter dated March 26, 2009 from MP Laboratories (Mauritius) Ltd ("MP Laboratories"), a wholly-owned subsidiary of Mylan Inc and one of the promoters of the Company, proposing a voluntary delisting offer to the public shareholders of the Company in accordance with the Securities and Exchange Board of India (Delisting of Securities) Guidelines, 2003 ("Delisting Guidelines") with a view to acquire the remaining public shareholding of the Company and to delist the equity shares of the Company from the Bombay Stock Exchange Limited ("BSE") and the National Stock Exchange of India Limited ("NSE") in accordance with the provisions of the Delisting Guidelines. The letter also states that MP Laboratories has approved an indicative price upto Rs. 150 per share for acquisition of the shares tendered under the delisting offer, subject to MP Laboratories' right under the Delisting Guidelines to accept or reject any price discovered under the reverse book building process set forth therein. MP Laboratories has requested the board of directors of the Company to convene an extra-ordinary general meeting of the shareholders of the Company for considering a proposal to pass a special resolution approving the proposed delisting offer as required by the Delisting Guidelines". Further the Company has submitted a copy of the letter dated March 26. 2009 received from MP Laboratories. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 23 Mar · Results

      Notice of Declaration of Results of Postal Ballot in respect of the Resolution for Retention of the sum of Rs. 37,50,000/- by Mr Jagdish Dore, erstwhile Director, Managing Director & Chief Executive Officer of the Company, which was paid to him by way of joining bonus on his joining the Company. Further, the Company has informed as follows: Result :- Approved by requisite majority. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.

    • 13 Mar · Business

      Press release dated March 12, 2009, titled "Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat - stable Version of HIV Protease Inhibitor". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  7. Feb 2009

    • 26 Feb · Business

      Press release dated February 25, 2009, titled "Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  8. Jan 2009

    • 28 Jan · Board meeting

      At the meeting of the Board of Directors of the Company, held on January 28, 2009 the Board has approved: (a) conversion of 1000 partly paid up equity shares of Rs.2/- each into fully paid up equity shares on account of receipt of calls in arrears. (b) forfeiture of 15500 partly paid up equity shares of Rs.2/- each, on account of non receipt of calls in arrears. The details of the forfeited shares shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 28 Jan · Results

      Standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 39415 lacs for quarter ending on 31-DEC-2008 against Rs. 27571.9 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 3614 lacs for the quarter ending on 31-DEC-2008 against Rs. 3434.9 lacs for the quarter ending on 31-DEC-2007.

    • 28 Jan · Results

      Consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 58065 lacs for quarter ending on 31-DEC-2008 against Rs. 45354 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. (3292) lacs for the quarter ending on 31-DEC-2008 against Rs. 1444 lacs for the quarter ending on 31-DEC-2007.

    • 19 Jan · Board meeting

      Inter alia to consider and approve the "Unaudited Financial Results" of the Company for the third quarter and nine months ended December 31, 2008.

    • 15 Jan · Business

      Press release dated January 14, 2009, titled "Matrix Assigns Part of its Astrix Purchase Rights to Parent Company". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  9. Dec 2008

    • 26 Dec · Management

      Board of Directors through circular resolution: 1) Accepted the resignation tendered by Mr. Jagdish Vishwanath Dore from the offices of Managing Director, Director, and Chief Executive Officer with effect from close of business on December 31, 2008. The Board placed on record its appreciation for the valuable services rendered by Mr. Dore during his tenure with Matrix. 2) Promoted Mr. S. Srinivasan, who is currently serving the Company as Chief Operating Officer, as its Chief Executive Officer with effect from January 01, 2009. 3) Approved the appointed of Mr. S. Srinivasan as an Additional Director of the Company with effect from January 01, 2009. 4) Approved the appointed of Mr. S. Srinivasan as its Managing Director with effect from January 01, 2009. 5) Promoted Dr. Hari Babu, Head of Global API Manufacturing, as its Chief Operating Officer with effect from January 01, 2009. 6) Reconstituted the following Committee of the Board as under: Name of Committee: a) Compensation Committee: Details of the Membership: Mr. K.R.V. Subrahmanian- Chairman; Dr. Fred E Cohen- Member; Mr. S.Srinivasan- Member. b) Executive Committee: Details of the Membership: Mr. N. Prasad- Chairman; Mr. S.Srinivasan- Member; Mr. Rajiv Malik- Member; Mr. C. Ramakrishna- Member; c) Share Transfer Committee: Mr. C. Ramakrishna- Chairman; Mr. S. Srinivasan- Member. Further, the Company has submitted to the Exchange a copy of press release titled "Matrix Laboratories Appoints S. Srinivasan as Managing Director and CEO, Promotes B. Hari Babu, Ph.D., to Chief Operating Officer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  10. Nov 2008

    • 10 Nov · Updates

      Notice regarding payment of calls-in-arrears from the partly paid-up shareholders of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  11. Oct 2008

    • 30 Oct · Board meeting

      Board of Directors of the Company at its meeting held on October 29, 2008, the Board approved: 1) Conversion of 6718 partly paid up equity shares of Rs.2/- each into fully paid up equity shares on account of receipt of calls-in-arrears. 2) Issue of a Final Notice to the Shareholders holding 16500 partly paid up Equity Shares of Rs.2/- each, advising them to remit the calls-in-arrears along with the interest on or before December 02, 2008.

    • 30 Oct · Results

      Consolidated Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 104760 lacs for half year ending on 30-SEP-2008 against Rs. 84007.3 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 1261 lacs for the half year ending on 30-SEP-2008 against Rs. 1429.1 lacs for the half year ending on 30-SEP-2007.

    • 30 Oct · Results

      Consolidated Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 51439 lacs for quarter ending on 30-SEP-2008 against Rs. 38537.8 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 889 lacs for the quarter ending on 30-SEP-2008 against Rs. (1059.1) lacs for the quarter ending on 30-SEP-2007.

    • 30 Oct · Results

      Standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 64189 lacs for half year ending on 30-SEP-2008 against Rs. 42799.3 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 8203 lacs for the half year ending on 30-SEP-2008 against Rs. 3943.2 lacs for the half year ending on 30-SEP-2007.

    • 30 Oct · Results

      Standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 32483 lacs for quarter ending on 30-SEP-2008 against Rs. 21322.5 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 4966 lacs for the quarter ending on 30-SEP-2008 against Rs. 1364 lacs for the quarter ending on 30-SEP-2007.

    • 21 Oct · Board meeting

      Inter alia to consider and approve the "Unaudited Financial Results" of the Company for the second quarter and half-year ended September 30, 2008.

    • 16 Oct · Meeting

      Proceedings of the Annual General Meeting of the Company held on September 15, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 10 Oct · Business

      Press release dated October 09, 2008, titled "Matrix And Aspen Agree To Divest Joint Ventures". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  12. Sep 2008

    • 16 Sep · Meeting

      All resolutions placed at the Annual General Meeting of the Company held on September 15, 2008, in terms of the Notice dated August 14, 2008, have been unanimously passed by the Members of the Company. The copy of the notice of said AGM shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  13. Aug 2008

    • 19 Aug · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30, 2008 and the details of the same are available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.

    • 13 Aug · Meeting

      Annual General Meeting of the Company will be convened on September 15, 2008. The Register of Members and Share Transfer Books of the Company will be closed from September 11, 2008 to September 15, 2008 for the purpose of holding the Annual General Meeting.

How the price met the news

The first session after each announcement, beside the market.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

  • 26 Jul 2007Board or managers changedup 0.50%0.0 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−0.4 pts vs Nifty 500) · volume 1.5× usual

Sharp moves

15 of the 23 shown had no filing that day or the next.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

  • 28 May 20091 filingup 14.04%+12.7 pts vs Nifty 5003.7× its usual move · volume 13.3× usual
  • 27 Mar 20092 filingsup 19.98%+18.7 pts vs Nifty 5003.9× its usual move · volume 0.4× usual
  • 18 Mar 2009No filing that day or the nextup 11.54%+10.6 pts vs Nifty 5002.3× its usual move · volume 4.5× usual
  • 20 Feb 2009No filing that day or the nextup 10.34%+12.2 pts vs Nifty 5002.0× its usual move · volume 2.4× usual
  • 7 Jan 2009No filing that day or the nextdown 18.41%−11.8 pts vs Nifty 5002.6× its usual move · volume 1.1× usual
  • 31 Dec 2008No filing that day or the nextdown 11.85%−11.5 pts vs Nifty 5001.7× its usual move · volume 14.1× usual
  • 30 Dec 2008No filing that day or the nextup 17.38%+15.4 pts vs Nifty 5002.7× its usual move · volume 8.0× usual
  • 18 Nov 2008No filing that day or the nextdown 14.47%−10.7 pts vs Nifty 5002.5× its usual move · volume 0.3× usual
  • 17 Nov 2008No filing that day or the nextdown 16.58%−13.8 pts vs Nifty 5003.1× its usual move · volume 0.3× usual
  • 4 Nov 2008No filing that day or the nextup 10.80%+7.4 pts vs Nifty 5002.1× its usual move · volume 1.5× usual
13 earlier moves
  • 3 Nov 2008No filing that day or the nextup 11.06%+5.9 pts vs Nifty 5002.3× its usual move · volume 1.4× usual
  • 27 Oct 2008No filing that day or the nextdown 14.81%−11.8 pts vs Nifty 5003.3× its usual move · volume 3.9× usual
  • 8 Oct 20081 filingdown 21.01%−17.5 pts vs Nifty 5006.5× its usual move · volume 3.3× usual
  • 19 Sep 2008No filing that day or the nextup 10.16%+5.6 pts vs Nifty 5003.2× its usual move · volume 2.0× usual
  • 1 Jul 20084 filingsdown 11.96%−8.0 pts vs Nifty 5004.5× its usual move · volume 2.5× usual
  • 28 Mar 20081 filingup 15.02%+12.2 pts vs Nifty 5003.1× its usual move · volume 2.5× usual
  • 17 Mar 2008No filing that day or the nextdown 12.37%−6.5 pts vs Nifty 5002.7× its usual move · volume 0.8× usual
  • 14 Feb 2008No filing that day or the nextup 16.34%+10.7 pts vs Nifty 5004.3× its usual move · volume 1.4× usual
  • 21 Jan 2008No filing that day or the nextdown 18.69%−8.5 pts vs Nifty 5006.7× its usual move · volume 0.6× usual
  • 12 Nov 20071 filingup 11.05%+11.8 pts vs Nifty 5004.3× its usual move · volume 0.9× usual
  • 5 Sep 2007No filing that day or the nextup 8.53%+8.5 pts vs Nifty 5004.2× its usual move · volume 9.8× usual
  • 24 May 20072 filingsup 10.91%+11.5 pts vs Nifty 5003.5× its usual move · volume 7.6× usual
  • 14 May 20071 filingup 12.65%+11.3 pts vs Nifty 5004.6× its usual move · volume 7.8× usual